Selegiline Alleviates the Depressive-Like Behaviors of Methamphetamine Withdrawal Syndrome Through Modulating Mitochondrial Function and Energy Hemostasis

Background: Methamphetamine (METH) is considered the second most commonly abused drug in the world. There is limited or no evidence concerning the effective treatment of METH withdrawal symptoms, such as depression and anxiety. Mode of action of selegiline (increase of the brain neurotransmitter act...

Description complète

Détails bibliographiques

Auteurs principaux:	Mir-Jamal Hosseini, Sima Askari Sadat-Mahaleh, Hamed Ghavimi
Format:	Artigo
Langue:	Inglês
Publié:	Tabriz University of Medical Sciences 2022-04-01
Collection:	Pharmaceutical Sciences
Sujets:	selegiline methamphetamine depression mitochondrion oxidative stress fluoxetine
Accès en ligne:	https://ps.tbzmed.ac.ir/PDF/ps-28-251.pdf
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!